Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype Prospective Outcomes (ILD-PRO) Registry

Project: Research project

Project Details

StatusActive
Effective start/end date8/21/20 → 8/21/21

Funding

  • Duke University (Prot #STU00212090)
  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #STU00212090)
View all
View less